Pamela L. Kunz, MD
PAMELA L. KUNZ, MD, has been appointed Leader of the Gastrointestinal Cancers Program at Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center and Director of GI Medical Oncology within the Section of Medical Oncology.
Dr. Kunz joins Yale from Stanford University School of Medicine in Palo Alto, where she is currently Director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Research Group, and Director of the Neuroendocrine Tumor Fellowship.
Leader in Treatment of Neuroendocrine Tumors
“BEYOND HER RECORD of accomplishment in GI Oncology, Dr. Kunz is an international leader in the clinical care of patients with neuroendocrine tumors and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this difficult diagnosis,” said Charles Fuchs, MD, MPH, Director of Yale Cancer Center and Physician-in-Chief at Smilow Cancer Hospital.
Charles Fuchs, MD, MPH
Previously, Dr. Kunz served as Chief Resident in Internal Medicine and completed a Clinical and Research Fellowship in Medical Oncology at Stanford University. She will start her new position in July 2020.
